Award Notice for the instruments and reagents to perform automated microbial identification and susceptibility testing for the Brooke Army Medical Center (BAMC), Department of Pathology and Area Laboratory Services

Where this opportunity stands

Every notice posted under solicitation W81K00-26-P-A114 in this department, oldest first.

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

• Note the winner and the end of the period of performance for the recompete.
• Follow the agency to see the next notice for this work.

What the notice says

Who won similar work

15 award notices on SAM.gov in the last 24 months. Matched by: Same office (W40M MRC0 WEST), same NAICS 325413.

Single-winner award sizes (15): middle half $229K to $1.5M, median $483K; range $70K to $542.4M.

Value counts new single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling (same contract, or the same office, day and amount); that ceiling is not one company's win, so it is not added in. Contract modifications are not new awards and are not added in either. Notices whose amount is a placeholder such as $999,999,999 are not added in. Revenue next to a ticker is the company's revenue over the latest 12 months in its SEC filings.

• Jul 14, 2026MERIDIAN BIOSCIENCE INC$151KNotice of Award to Meridian BioscienceNo listed company matched (Materiality N/A)
• Jun 17, 2026SYSMEX AMERICA, INC$2.3MAward Notice for cost-per-test agreement for cost-per-reportable result (CPRR) agreement for the Hematology Testing Agreement at the Brooke Army Medical Center in San Antonio, Texas.No listed company matched (Materiality N/A)
• Mar 19, 2026VENTANA MEDICAL SYSTEMS, INC$1.4MNotice of Sole Source AwardNo listed company matched (Materiality N/A)
• Mar 5, 2026SIEMENS HEALTHCARE DIAGNOSTICS INC.$662KIntegrated Immunoassay and Chemistry Analyzer Reagents and ConsumablesNo listed company matched (Materiality N/A)
• Jan 20, 2026ABBOTT MOLECULAR INC.$1.5MRT-PCR Molecular Testing for Transplant, Respiratory, and Sexual Health Infections Department of Pathology and Area Laboratory Services (DPALS)Materiality: <0.01% of $ABT revenue (Low)Calculated as Award Amount divided by the company's trailing twelve-month revenue (SEC 10-Q). Here: $1.5M award ÷ $45.1B revenue, 12 months to Mar 31, 2026 (SEC 10-Q). SEC
• Jan 20, 2026ROCHE DIAGNOSTICS CORPORATION$7.0MHistologyNo listed company matched (Materiality N/A)
• Sep 17, 2025WERFEN USA LLC$246KHematology Analyzers and ReagentsNo listed company matched (Materiality N/A)
• Sep 10, 2025HOLOGIC SALES AND SERVICE, LLC$211KAward NoticeNo listed company matched (Materiality N/A)
• Aug 26, 2025ROCHE DIAGNOSTICS CORPORATION$70KAward Notice H&E Stainer Lease and Reagents Cost Per Test (CPT)No listed company matched (Materiality N/A)
• Aug 19, 2025DIASORIN INC$467KNotice of Award and Redacted J&A Leased Automated Immunoassay Analyzers and ReagentsNo listed company matched (Materiality N/A)

Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.

Competitive landscape

For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.